by Gordon Hensley | Apr 11, 2020 | advocacy, Business, lobbying, polling
With the onset of the COVID-19 pandemic, DC consultants, lobbyists, data specialists and others are scrambling for their lives, and indeed, their very livelihoods. Clients representing both vast sectors as well as smaller sub-sectors of the U.S. economy are shelling...
by Gordon Hensley | Mar 26, 2019 | advocacy, Business, GOP Politics, health care, lobbying, Pharmaceutical
This more of an addenda to my last post noting how PBMs have, to their detriment, ended up on Sen. Grassley’s radar screen. Now Sen. John Cornyn (R-TX), up for reelection this cycle, has weighed in: “The whole rebate thing just looks kind of — well...
by Gordon Hensley | Feb 21, 2019 | advocacy, Business, CMS, health care, lobbying, Medicare Cuts, Pharma, U.S. House, U.S. Senate
Among the most complex but significant issues in the unfolding debate about prescription drug pricing reform is pharmacy benefit manager (PBM) rebates — or, so-called “rebates” — as many objective observers see them as kickbacks or opaque...
by Gordon Hensley | Feb 25, 2018 | advocacy, Business, lobbying, Media Relations, polling, Trump
The #1 Axios item today, “1 big thing: United States of Corporate America,” points out that “corporate social responsibility” (shorthanded as “CSR” within companies) is now one of the hottest topics in boardrooms… as corporate...
by Gordon Hensley | Jul 28, 2017 | advocacy, Business, lobbying, Television, Trump
While much of the conversation and news coverage over the past several months has been usurped by health reform and the daily drama within the Trump White House, the clear escalation of the Beltway media war between Saudi Arabia and Qatar is shaping up as a...